ZNU-11261-11781
4 vaccinations
7 coded responses
48 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 023 / MA
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Pfizer-BioNTech
- 2021-02-05
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
-
2021-02-26
Dose 2 — Pfizer-BioNTech
- 2021-02-26
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
-
2021-05-28
Survey response — 3 months, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-27
-
2021-12-12
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
- 2022-01-23
-
2022-03-13
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: I had a sinus cold.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-12
-
2022-10-09
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-23
-
2022-10-30
Survey response — day 21, dose 4MedDRA: Fatigue, Rhinorrhoea — Feeling: GoodFree text: Fatigue, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Survey response — day 28, dose 4MedDRA: Influenza like illness, Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold/flu-like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-11-13
Survey response — day 35, dose 4MedDRA: COVID-19, Malaise — Feeling: Good · Be unable to do your normal daily activitiesFree text: I was sick with covidMedDRA releases: 2024-11 · check-in free text available
- 2022-11-20
-
2023-01-08
Survey response — 3 months, dose 4MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-01-08
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2023-01-09
Call successfulNot applicable - Accidental Reporting
-
2023-04-11
Survey response — 6 months, dose 4MedDRA: Seizure — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-11
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-02-26 | Pfizer-BioNTech | |
| 3 | 2021-12-12 | Pfizer-BioNTech | No |
| 4 | 2022-10-09 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-08 | Successful 2023-01-09 |
Not applicable - Accidental Reporting |
| 2023-04-11 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: None
Release 11 — 3 months, dose 3
Symptoms: I had a sinus cold.
Release 12 — day 21, dose 4
Symptoms: Fatigue, runny nose
Release 12 — day 28, dose 4
Symptoms: Cold/flu-like symptoms
Release 12 — day 35, dose 4
Symptoms: I was sick with covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | No adverse event | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Seizure | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release